Mirum Pharmaceuticals CEO Christopher Peetz's 2022 pay rises 7% to $4.4M
Mirum Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: May 1, 2023
Mirum Pharmaceuticals reported fiscal year 2022 executive compensation information on May 1, 2023.
In 2022, four executives at Mirum Pharmaceuticals received on average a compensation package of $2.2M, a 9% decrease compared to previous year.
Average pay of disclosed executives at Mirum Pharmaceuticals
Christopher Peetz, Chief Executive Officer, received $4.4M in total, which increased by 7% compared to 2021. 61% of Peetz's compensation, or $2.7M, was in option awards. Peetz also received $449K in non-equity incentive plan, $624K in salary, $635K in stock awards, as well as $12K in other compensation.
Peter Radovich, Chief Operating Officer, received a compensation package of $1.6M, which decreased by 13% compared to previous year. 43% of the compensation package, or $671K, was in option awards.
Lara Longpre, Chief Development Officer, earned $1.5M in 2022.
Pamela Vig, Head of Research and Development, received $1.5M in 2022.
Related executives
You may also like
Source: SEC filing on May 1, 2023.